文献速递炎症性肠病

肠道炎症调节ACE2与TMPRSS2表达并可能与SARS-CoV-2相关疾病发病机制重叠

Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.
PubMed 文献 · Gastroenterology · 2020-09-25

该研究在多个大型炎症性肠病(IBD)患者队列中,探讨了COVID-19、肠道炎症与IBD治疗之间的交叉点。研究发现小肠肠细胞刷状缘上ACE2的显著表达支持SARS-CoV-2的肠道感染性;常用IBD药物(生物制剂和非生物制剂)对未发炎肠道中ACE2和TMPRSS2受体表达无显著影响;并定义了COVID-19感染中同样富集于IBD的分子反应,提示COVID-19与IBD之间存在共享分子网络。

要点

  • 小肠肠细胞刷状缘ACE2显著表达,支持SARS-CoV-2肠道感染性。
  • 常用IBD药物(生物制剂和非生物制剂)对未发炎肠道ACE2和TMPRSS2表达无显著影响。
  • COVID-19感染中定义的分子反应同样富集于IBD,提示两者共享分子网络。

核心结论

  • 这些数据对COVID-19与IBD相关炎症的汇合产生了新的认识,并提供机制见解支持进一步研究特定IBD药物治疗COVID-19。

研究设计与样本

  • 研究在多个大型炎症性肠病(IBD)患者队列中,研究了COVID-19、肠道炎症与IBD治疗之间的交叉点。

主要发现

  • 小肠肠细胞刷状缘上ACE2的显著表达支持SARS-CoV-2的肠道感染性。
  • 常用IBD药物,包括生物制剂和非生物制剂,对未发炎肠道中ACE2和TMPRSS2受体表达无显著影响。
  • 定义了COVID-19感染中同样富集于IBD的分子反应,指向COVID-19与IBD之间的共享分子网络。

临床怎么用

  • 作者认为这些数据提供机制见解,支持进一步研究特定IBD药物治疗COVID-19。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The presence of gastrointestinal symptoms and high levels of viral RNA in the stool suggest active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication within enterocytes. METHODS: Here, in multiple, large cohorts of patients with inflammatory bowel disease (IBD), we have studied the intersections between Coronavirus Disease 2019 (COVID-19), intestinal inflammation, and IBD treatment. RESULTS: A striking expression of ACE2 on the small bowel enterocyte brush border supports intestinal infectivity by SARS-CoV-2. Commonly used IBD medications, both biologic and nonbiologic, do not significantly impact ACE2 and TMPRSS2 receptor expression in the uninflamed intestines. In addition, we have defined molecular responses to COVID-19 infection that are also enriched in IBD, pointing to shared molecular networks between COVID-19 and IBD. CONCLUSIONS: These data generate a novel appreciation of the confluence of COVID-19- and IBD-associated inflammation and provide mechanistic insights supporting further investigation of specific IBD drugs in the treatment of COVID-19. Preprint doi: https://doi.org/10.1101/2020.05.21.109124.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Suárez-Fariñas M, Tokuyama M, Wei G, et al. Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease. Gastroenterology. 2020. PMID: 32980345. doi:10.1053/j.gastro.2020.09.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。